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Abstract Although in the past cochlear implantation was
considered contraindicated in patients with acute (AOM) or
chronic suppurative otitis media (CSOM) with or without
middle ear cholesteatoma, recent developments now make
it possible to perform cochlear implantation in these
patients. Various procedures are available to make the ears
of patients with either acute or CSOM suitable for cochlear
implantation and to minimize the risk of recurrence of the
disease, device extrusion, or intracranial complications.
This review discusses these diVerent approaches for opti-
mizing implant survival and preventing complications
related to otitis media. We performed a comprehensive lit-
erature search of the MEDLINE database. Cochlear
implantation can be safely performed in patients with otitis
media. However, the infection should be adequately con-
trolled well before implantation, and all measures should be
taken to prevent recurrent disease. Therefore, the procedure
used should be tailored to individual clinical Wndings. This
article provides a guideline to optimize the course of action
in patients suVering from AOM, CSOM or their sequelae in
preparation for cochlear implantation.
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Introduction
Acute otitis media (AOM) is the most common pediatric
infection, with an incidence of 60–80% in the Wrst 6 years
of life and a high risk of recurrence. Therefore, many young
deaf patients are eligible to receive a cochlear implant
suVer from otitis media. Chronic suppurative otitis media
(CSOM) can cause several problems, beside chronic otor-
rhea, that may give rise to sensorineural hearing loss, and
thus may be a coincidental Wnding or the cause of deafness
in patients requiring a cochlear implant (CI).
In the past, cochlear implantation was contraindicated in
patients with otitis media [1], because of the risk of meningi-
tis, tympanic membrane perforation, recurrent cholestea-
toma, and extrusion of the electrode in a radical cavity
because of breakdown of the thin epithelial lining. Moreover,
the development of otitis media after implantation may cause
intracranial complications or device extrusion or necessitates
device removal. Despite these potential problems, there is
sometimes no choice but to perform cochlear implantation in
an “infected” ear; for example, if the patient has bilateral oti-
tis media or if the patient has one-sided otitis media but the
other ear is unsuitable for device implantation because of
residual hearing, anatomical variations, or obstruction of the
cochlear lumen. A pre-operative CT-scan is made to evaluate
cochlear patency and anatomical malformations. Further-
more, this CT-scan may provide additional information about
the pathology, as discussed in this article. MRI will be com-
plementary to detect or eliminate partial or total obliteration
of the cochlear duct due to Wbrosis or ossiWcations.
The aim of this article was to review the literature on
cochlear implantation in relation to acute and CSOM and
its consequences. We discuss the diVerent approaches used
for optimizing implant survival and for preventing compli-
cations associated with otitis media.
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We performed a comprehensive literature search of the
MEDLINE database, using the following key words:
cochlear implantation or cochlear implant and otitis media
or CSOM or tympanic membrane perforation or radical
cavity or cholesteatoma. We selected relevant articles based
on the articles’ title and abstract.
Acute otitis media
Acute otitis media (AOM) is the most common bacterial
infection among children; by 3 years of age, 50–85% of
children have had AOM [2]. Moreover, recurrent infections
are common, aVecting 10–20% of children by age 1 year
[2]. Therefore, an acute infection or a recent history of
(recurrent) OM is observed relatively frequent in children
who require a CI, especially in early implantation. Although
in the past, OM was considered a risk factor for complica-
tions after implantation, delaying cochlear implantation in
OM-prone children until they have outgrown their suscepti-
bility to otitis media has signiWcant repercussions on
speech-language and educational development [2]. Recent
reports have demonstrated that cochlear implantation can be
performed safely in patients with a history of AOM and that
a signiWcant delay is not warranted in these patients [3–5]. A
prospective study [4, 5], with a cohort of 60 children, of
which 34 were classiWed as OM-prone, demonstrated that if
control of OM is achieved before cochlear implantation, the
incidence of AOM decreases post-implantation. Moreover,
no complications were seen in the OM-prone children
receiving a cochlear implant, even in the children suVering
an episode of AOM post-implantation.
It should be emphasized that in all these studies [3–5],
the infection was under control before cochlear implanta-
tion. If this is not the case, an increased risk of bacterial con-
tamination of the device or meningitis could be expected.
This control of AOM before implantation can be achieved
conservatively with pain medication or antibiotics. How-
ever, in patients with a recent history of recurrent OM or in
children with a high risk of recurrence due to their age, ven-
tilating tubes may be more eVective than antibiotics. Addi-
tional treatments, such as adenoidectomy, may also be of
use [3–6]. Patients with a dry, clean ventilation tube in place
can receive an implant without further delay [6].
If it is adequately controlled, (recurrent) AOM should not
be considered a contraindication for cochlear implantation,
and implantation in such children should not be postponed.
Tympanic membrane perforation
The tympanic membrane may be perforated, without signs
of inXammation, in patients with a history of either acute or
chronic otitis media. In the case of a simple, dry, tympanic
membrane perforation, several authors recommend repair of
the perforation Wrst, followed by cochlear implantation, if
the drum has been intact for at least 3 months [7–10]. How-
ever, these studies retrospectively described only six patients
in total with a tympanic membrane perforation. Myringo-
plasty performed simultaneously with cochlear implantation
would seem the most straightforward procedure, but repair
of the tympanic membrane perforation occasionally requires
more than one procedure [7], and myringoplasty failure
would leave the electrode vulnerable to the external environ-
ment. Therefore, some authors have used other techniques in
a single-stage procedure with cochlear implantation, such as
meatal closure [11–13] or radical mastoidectomy with com-
plete obliteration of the cavity [8, 14]. Meatal closure carries
the disadvantage that otoscopic visualization is not possible
in these patients, and thus early diagnosis and treatment of
infection, which is necessary to minimize the risk of menin-
gitis, is more diYcult.
We suggest that a distinction should be made between
small and large perforations. As patients with a dry, clean ven-
tilation tube, in place can undergo cochlear implantation
(without prior tube removal) without an increased risk of
complications [6], it would appear safe to place an implant
when there is a persistent small tympanic membrane perfora-
tion. Therefore, such patients do not need to undergo myrin-
goplasty followed by device implantation during a later
procedure. However, if the perforation is large, the electrode is
more vulnerable to the external environment, which increases
the likelihood of infection or damage. Therefore, it is always
appropriate to protect the electrode if there is a large perfora-
tion. If myringoplasty is unsuccessful, one option is to repeat
the procedure and to delay cochlear implantation by at least
another 3 months, to allow the perforation to close or at least
become smaller. Another option is to perform either meatal
closure or radical mastoidectomy in conjunction with cochlear
implantation, but this complex procedure is associated with
additional complications. It should be borne in mind that clo-
sure of the perforation, to protect the electrode array in the
middle ear, might reactivate the CSOM. This makes it inad-
visable, even if the perforation is small, to perform myringo-
plasty and cochlear implantation at the same time.
Therefore, in patients with a dry tympanic membrane
perforation, repair of the perforation and cochlear implanta-
tion in a staged procedure appears to be the best solution. In
the case of chronic purulent discharge from a tympanic
membrane perforation, the ear should be treated as any ear
with active CSOM, as mentioned later.
CSOM or cholesteatoma
Cochlear implantation in patients with persistent purulent
discharge from an ear because of CSOM, middle ear123
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(the sequelae of) CSOM, active and inactive, in patients
receiving a CI is relatively rare, and is highly dependent on
institutional policies (2.2–10.9%) [7, 8, 17]. Therefore, the
exact risk of complications in these patients is not known.
Although only few documented cases exist [15, 16], there is
a potential danger of device extrusion, meningitis, and
other intracranial complications in these patients. There-
fore, it is essential to completely eradicate the disease
before implantation, to prevent recurrent or residual infec-
tion or cholesteatoma in the implanted ear. Donnelly et al.
[15] describe three patients with a history of CSOM who
underwent mastoidectomy before implantation, all suVering
from recurrent CSOM post-implantation [15]. Therefore,
conservative management, such as antibiotics, and conven-
tional surgical management, such as ventilating tubes, mas-
toidectomy, or tympanoplasty, does not seem to suYciently
eliminate the risk of recurrence. Especially in case of cho-
lesteatoma, intact canal wall tympano mastoidectomy or
radical mastoidectomy is the most thorough technique to
clear the ear of disease and are recommended for this rea-
son [7, 8, 10, 17, 18]. Four retrospectively conducted stud-
ies describe in total 14 patients with active CSOM, with or
without cholesteatoma and with or without previous mas-
toidectomy, in which this procedure was carried out with-
out complications post-implantation [7, 8, 17, 18].
Most surgeons prefer a staged procedure for implantation
in patients with purulent CSOM or cholesteatoma [7, 8, 10,
14, 17–21]. In the case of CSOM, a CI can be placed after a
delay of 3–6 months if the disease is eradicated [7, 18, 19].
The presence of cholesteatoma should be re-evaluated after
at least 6–12 months and, therefore, cochlear implantation
must be delayed by the same time [7, 18–20]. This means
that implantation is signiWcantly delayed, especially if the
ear is not healthy after the Wrst procedure, and this delay
may be problematic especially in children. Moreover,
despite repeated procedures, it may not be possible to com-
pletely and permanently cure the infection or eradicate all
cholesteatoma. In these cases, the disease may be brought
under control with repeated cleaning, after which cochlear
implantation can go ahead. The patient should be informed
of the increased risk and should be followed up vigilantly.
A single-stage procedure has been proposed that can be
performed in the presence of cholesteatoma. The investiga-
tors argued that residual or recurrent cholesteatoma could
occur at any time postoperatively and that there is no evi-
dence of a second look for cholesteatoma before implanta-
tion prevents the implant from destructive recurrent
cholesteatoma [22]. However, because of the potentially
devastating risks of residual cholesteatoma in patients with
a CI, and because diagnosis of cholesteatoma is compli-
cated when obliterative techniques have been used, we
would strongly advise against this policy.
Therefore, it is advisable to perform an intact canal wall
tympanomastoidectomy or a radical mastoidectomy in
patients with active CSOM, with or without cholesteatoma,
followed by cochlear implantation in a second procedure
once the ear is considered healthy.
Radical cavities
In the case of a radical cavity without active disease, after
treatment of active disease in a radical cavity, or after crea-
tion of a radical cavity to resolve CSOM or cholesteatoma,
special measures should be taken to protect the electrode in
its passage through the cavity. The thin epithelial lining of
the mastoid cavity is nearly always insuYcient to protect
any kind of implanted foreign body itself and, therefore,
simply inserting the electrode under the epithelial lining
leaves it vulnerable to exposure [7, 17, 18, 23–26, 29].
Although the exact rate of electrode extrusion and its possi-
ble consequences are not known, diVerent techniques have
been developed to protect the electrode.
It is possible to obliterate the cavity completely using
abdominal fat [8, 10, 14, 19, 20, 25], a pedicled temporalis
muscle Xap [7, 9, 10, 17, 22], or a combination of both [27].
In the case of total obliteration, the Eustachian tube is oblit-
erated as well and the external ear canal is closed as a blind
sac. The cavity can be Wlled with bone dust, hydroxyapatite,
and tricalcium phosphate. However, anatomical landmarks
may be obscured and it may be necessary to drill at the time
of cochlear implantation in a second procedure [20]. More-
over, hydroxyapatite and tricalcium phosphate carry the
danger of infection and extrusion. The most suitable mate-
rial to obliterate the cavity appears to be abdominal fat
because of its resistance to necrosis and easy removal if
cochlear implantation is performed later.
Entrapment of squamous epithelium is a potentially seri-
ous complication of obliterative surgery. Magnetic reso-
nance imaging cannot be performed in these patients
because of the magnet and the signal void around the
implanted metal. High-resolution computed tomography
can be performed, but Wndings are diYcult to interpret and
the predictive value is low. Because it is easier to distin-
guish the contours of cholesteatoma from air than from
muscle or fat, it is considered preferable to leave the middle
ear, the mastoid cavity, or both, aerated. Techniques have
been developed to make this possible. One such technique,
reconstruction of a new posterior canal wall [28], is not
considered as advantageous because it involves compli-
cated surgery, postoperative healing problems, and a risk of
epithelial entrapment and will, therefore, not be discussed
in detail.
Non-obliterative techniques involve drilling of the bed
for the receiver-stimulator in a posterior position than in a
standard procedure [18, 21, 26, 29, 30]. Furthermore, the123
174 Eur Arch Otorhinolaryngol (2009) 266:171–176groove for the electrode outside the cavity is shaped in a
wave-like form [21, 29, 30]. As a result, the main length of
the array lies outside the mastoid cavity, which reduces the
risk of ulceration and necrosis of the covering Xaps or skin.
Subsequently, bone dust and Wbrin glue can be used to
cover the electrode in its tract within the cavity, resulting in
a Xat surface [18, 21, 26, 29]. If necessary, this surface can
be covered with cartilage [21, 29], temporal fascia [18, 21],
a periosteal Xap [29], a pedicled temporal muscle Xap [18,
26], or any combination of the materials mentioned above.
This results in a non-obliterated or partially obliterated cav-
ity, which can then be covered with the epithelial lining of
the cavity [21, 30]. Although all these studies represented
case reports of a maximum of three patients, together these
studies have reported 14 patients that were implanted using
this non-obliterative technique without any short- or long-
term complications. Therefore, this technique seems to be a
safe alternative for obliterative surgery in cochlear implan-
tation, without the complicated radiologic diagnosis of cho-
lesteatoma that is a consequence of obliteration.
Another non-obliterative technique involves the use of a
vascularized temporalis fascia Xap (‘Hong Kong Flap’)
after (revision) mastoidectomy to cover the cavity and
repair possible defects in the tympanic membrane after a
Wrst-stage procedure [31]. This technique was used in only
one patient receiving a CI. Moreover, a staged procedure is
advised to ensure viability and strength of the Xap to protect
the electrode by the time cochlear implantation is per-
formed. Consequently, this technique is not suitable if a
single procedure can be performed, such as when there is a
healthy radical cavity.
More recently, a non-obliterative technique with closure
of the external auditory meatus has been reported [11–13].
This technique can be performed in one or two stages,
depending on whether active disease is present. Otoscopic
examination of the cavity is not possible, but high-resolution
computed tomography, for the detection of cholesteatoma,
is. The mucosa, aeration of the mastoid and middle ear cav-
ity, and Eustachian tube are left patent in this procedure. The
latter is especially important because the Eustachian tube
could be a pathway for infection that is diYcult to diagnose
without the possibility of otoscopic examination.
In patients with CSOM, with or without cholesteatoma
or a radical cavity, it is also possible to place a CI via the
middle fossa approach [32]. This technique avoids the need
for multiple surgical procedures before implantation and
contamination of the middle ear. However, this approach
involves risks inherent to craniotomy and does not correct
the underlying problems associated with CSOM or choles-
teatoma. As such, it is not really an attractive alternative for
transmastoidal procedures.
We would recommend performing a non-obliterative
procedure after (revision) mastoidectomy to make the ear
of a patient with a radical cavity suitable for implantation
and to provide optimal electrode protection, preferably
without meatal closure so that the cavity can be easily visu-
alized.
Otitis media in follow-up after cochlear implantation
Even though the incidence of otitis media after implanta-
tion is lower than before implantion [3–5], it still occurs
frequently in children. This decreased incidence might be
due to rigorous preoperative management of otitis media,
the decrease in the incidence of otitis media with age, and
mastoidectomy performed during implantation [3–5]. If a
patient with a CI, regardless of age, develops AOM, prompt
treatment with antibiotics is recommended and most studies
do not show any subsequent otitis-media related inner ear
or intra-cranial complications [3–6]. Although antibiotics
are usually used conservatively in the Netherlands, patients
with a CI who develop an infection should be treated as
early as possible because of the potential risks. Ventilating
tubes are usually inserted before, during, or after implanta-
tion in children who are prone to otitis media, to prevent
recurrent episodes of otitis media.
Can we conclude that infection after implantation is easy
to treat and therefore not dangerous? Does this mean that
the surgical measures taken to prevent recurrent infection in
adults with CSOM are overdone? While AOM after
implantation is eVectively treated with antibiotics in
patients of all ages, chronic disease, with or without choles-
teatoma, is more hazardous and has obviously proved resis-
tant to treatment in the past. For this reason, more extensive
measures should be taken to prevent its recurrence after
implantation. Therefore, all patients with CSOM, a radical
cavity, tympanic perforation, or cholesteatoma should be
followed up regularly. Patients with CIs should be seen by
audiologists, but such patients with CSOM should also be
seen regularly by an otolaryngologist, in order to diagnose,
treat, or control a potential recurrent infection or cholestea-
toma as early as possible.
A history of ear disease appears to signiWcantly increase
the risk of infection post-implantation [33]. In theory, this
could also mean a higher risk of meningitis in these
patients, since pathogens isolated from patients with menin-
gitis after the perioperative period is the same as those that
cause otitis media [34]. In the past, the incidence of bacte-
rial meningitis was higher in patients with a CI than in the
general population [34, 35]. One type of implant seemed to
contribute to this higher incidence of meningitis, probably
due to its design and insertion, and has been removed from
the market. However, candidates for CIs may also have pre-
disposing factors that increase their risk of meningitis, such
as a higher incidence of inner-ear malformations or cere-
brospinal Xuid leaks. Furthermore, patients whose deafness123
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increased risk of subsequent attacks of meningitis [36]. It
has not yet been determined whether the implant, the pre-
existing risk factors, or a combination of both causes the
increased rate of meningitis observed among individuals
with CIs. More needs to be known about this, and to this
end, the incidence of bacterial meningitis in patients with
CIs should be compared to that of a comparable population
of patients with deafness.
In the Netherlands, all patients with a CI are vaccinated
against Haemophilus inXuenzae type B (Act-Hib, Aventis
Pasteur MSD) and Streptococcus pneumoniae (Pneumovax,
Aventis Pasteur MSD/Prevenar, Wyeth). We are aware that
vaccination does not completely protect the patient against
the development of meningitis and that a shift in pathogens
may be expected, which makes it more likely that other
pathogens will cause meningitis [37]. Nevertheless, vacci-
nating patients with a CI protects them from meningitis
caused by a considerable number of pathogens and is there-
fore a valuable instrument against meningitis.
Conclusion
Cochlear implantation is possible in patients with otitis
media if appropriate measures are taken to prepare the ear
for implantation and to minimize potential risks, such as
recurrence of the infection, entrapment of epithelium,
extrusion of the device, and meningitis. An appropriate pro-
cedure should be based on the individual clinical presenta-
tion at the initial evaluation for implantation. This article
provides a guideline to make this decision.
In summary:
• AOM Infection should be controlled before cochlear
implantation. A single acute infection can be treated con-
servatively, whereas ventilation tubes may be more eVec-
tive for recurrent AOM.
• Tympanic membrane perforation Myringoplasty and
cochlear implantation should be performed in a two-
staged procedure.
• Purulent CSOM, cholesteatoma Intact canal wall tympa-
noplasty or radical mastoidectomy should be performed,
followed by cochlear implantation in a second stage,
using a non-obliterative technique.
• Radical cavity A non-obliterative procedure with optimal
electrode protection should be performed, preferably
without meatal closure.
In conclusion, cochlear implantation can be safely per-
formed in patients with otitis media but it remains a chal-
lenging problem in which individualized, tailor-made
precautions should be taken.
ConXict of interest statement The authors declare that they have no
conXict of interest.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution Noncommercial License which permits any
noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited.
References
1. Belal A Jr (1986) Contraindications to cochlear implantation. Am
J Otol 7:172–175
2. Rovers MM, Schilder AGM, Zielhuis GA et al (2004) Otitis me-
dia. Lancet 363:465–473
3. Fayad JN, Tabaee A, Micheletto JN et al (2003) Cochlear implan-
tation in children with otitis media. Laryngoscope 113:1224–1227
4. Luntz M, Teszler CB, Shpak T et al (2001) Cochlear implantation
in healthy and otitis-prone children: a prospective study. Laryngo-
scope 111:1614–1618
5. Luntz M, Teszler CB, Shpak T (2004) Cochlear implantation in
children with otitis media: second stage of a long-term prospective
study. Int J Pediatr Otorhinolaryngol 68:273–280
6. Kennedy RJ, Shelton C (2005) Ventilation tubes and cochlear im-
plants: what do we do? Otol Neurotol 26:438–441
7. Axon PR, Mawman DJ, Upile T et al (1997) Cochlear implanta-
tion in the presence of chronic suppurative otitis media. J Laryngol
Otol 111:228–232
8. Incesulu A, Kocaturk S, Vural M (2004) Cochlear implantation in
chronic otitis media. J Laryngol Otol 118:3–7
9. Babighian G (1993) Problems in cochlear implant surgery. Adv
Otorhinolaryngol 48:65–69
10. Takahashi H, Naito Y, Fujiki N et al (2000) Cochlear implant sur-
gery in ears with chronic otitis media. Adv Otorhinolaryngol
57:93–95
11. El-Kashlan HK, Arts HA, Telian SA (2002) Cochlear implantation
in chronic suppurative otitis media. Otol Neurotol 23:53–55
12. El-Kashlan HK, Arts HA, Telian SA (2003) External auditory ca-
nal closure in cochlear implant surgery. Otol Neurotol 24:404–408
13. El-Kashlan HK, Telian SA (2004) Cochlear implantation in the
chronically diseased ear. Curr Opin Otolaryngol Head Neck Surg
12:384–386
14. Bendet E, Cerenko D, Linder TE et al (1998) Cochlear implanta-
tion after subtotal petrosectomies. Eur Arch Otorhinolaryngol
255:169–174
15. Donnelly MJ, Pyman BC, Clark GM (1995) Chronic middle ear
disease and cochlear implantation. Ann Otol Rhinol Laryngol Sup-
pl 166:406–408
16. Roehm PC, Gantz BJ (2006) Cochlear implant explantation as a
sequel of severe chronic otitis media: case report and review of the
literature. Otol Neurotol 27:332–336
17. Kim CS, Chang SO, Lee HJ et al (2004) Cochlear implantation in
patients with a history of chronic otitis media. Acta Otolaryngol
124:1033–1038
18. Himi T, Harabuchi Y, Shintani T et al (1997) Surgical strategy of
cochlear implantation in patients with chronic middle ear disease.
Audiol Neurootol 2:410–417
19. Gray RF, Irving RM (1995) Cochlear implants in chronic suppu-
rative otitis media. Am J Otol 16:682–686
20. Gray RF, Ray J, McFerran DJ (1999) Further experience with fat
graft obliteration of mastoid cavities for cochlear implants. J Lar-
yngol Otol 113:881–884
21. Marangos N, Laszig R (1997) Cochlear implant surgery and radi-
cal cavities. Adv Otorhinolaryngol 52:147–150123
176 Eur Arch Otorhinolaryngol (2009) 266:171–17622. Basavaraj S, Shanks M, Sivaji N et al (2005) Cochlear implanta-
tion and management of chronic suppurative otitis media: single
stage procedure? Eur Arch Otorhinolaryngol 262:852–855
23. Webb RL, Lehnhardt E, Clark GM et al (1991) Surgical complica-
tions with the cochlear multiple-channel intracochlear implant:
experience at Hannover and Melbourne. Ann Otol Rhinol Laryn-
gol 100:131–136
24. Cohen NL, HoVman RA, Stroschein M (1988) Medical or surgical
complications related to the Nucleus multichannel cochlear im-
plant. Ann Otol Rhinol Laryngol Suppl 135:8–13
25. Pasanisi E, Vincenti V, Bacciu A et al (2002) Multichannel co-
chlear implantation in radical mastoidectomy cavities. Otolaryn-
gol Head Neck Surg 127:432–436
26. Kiefer J, von Ilberg C (1997) Special surgical problems in cochlear
implant patients. Adv Otorhinolaryngol 52:135–139
27. Hamzavi J, Baumgartner W, Franz P et al (2001) Radical cavities
and cochlear implantation. Acta Otolaryngol 121:607–609
28. Tamura Y, Shinkawa A, Ishida K et al (1997) Cochlear implant af-
ter reconstruction of the external bony canal wall and tympanic
cavity in radically mastoidectomized patients with cholesteatoma.
Auris Nasus Larynx 24:361–366
29. Manrique M, Cervera-Paz FJ, Espinosa JM et al (1996) Cochlear
implantation in radical cavities of mastoidectomy. Laryngoscope
106:1562–1565
30. Karatzanis AD, Chimona TS, Prokopakis EP et al (2003) Co-
chlear implantation after radical mastoidectomy: management
of a challenging case. ORL J Otorhinolaryngol Relat Spec
65:375–378
31. Tong MC, van Hasselt CA (1997) Cochlear implant surgery in a
modiWed radical mastoidectomy cavity reconstructed utilizing the
Hong Kong vascularized temporalis fascia Xap technique. Adv
Otorhinolaryngol 52:151–154
32. Colletti V, Fiorino FG, Carner M et al (2000) New approach for
cochlear implantation: cochleostomy through the middle fossa.
Otolaryngol Head Neck Surg 123:467–474
33. Cunningham CD 3rd, Slattery WH 3rd, Luxford WM (2004) Post-
operative infection in cochlear implant patients. Otolaryngol Head
Neck Surg 131:109–114
34. Reefhuis J, Honein MA, Whitney CG et al (2003) Risk of bacterial
meningitis in children with cochlear implants. N Engl J Med
349:435–445
35. US Food Drug Administration (2003) Cochlear implants and men-
ingitis. FDA Consum 37:35
36. Bluestone CD (2003) Prevention of meningitis: cochlear implants
and inner ear abnormalities. Arch Otolaryngol Head Neck Surg
129:279–281
37. Sanders L (2005) Otitis media and cochlear implantation—point-
ers and pitfalls. Immunology and infection. Presented at the 5th
extraordinary international symposium on recent advances in otitis
media, Amsterdam, the Netherlands, 24–27 April 2005123
